As of 24:00 on February 13: A total of 63,851 cases were confirmed, 6,723 were cured and dischar ...

The stock currently trades at an attractive valuation. Eli Lilly's stock has been a strong winner over the past few years, ...

How does the central government plan the medical insurance reform? The world's first oral GLP-1 hypoglycemic drug! Novo Nordisk's Rybelsus is approved by the EU Zhengda Tianqing's new breast cancer ...

A study suggests that GLP-1 agonist drugs, like Ozempic, may reduce overdose risks and aid in addiction treatment. Further ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

INR:5106. mascot the school Major new policy: New version of basic clinic standards is here! Winner Medical's annual performance forecast: Net profit exceeds 3 ...

Not long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...

GLP-1, or Glucagon-like peptide-1, medications, similar to Ozemppic and Wegovy, are becoming more accessible, and while the ...

Mounjaro, which has been dubbed the "King Kong" of weight-loss drugs, is considered more effective than its competitors with ...

Musk has been an advocate for the widespread use of GLP-1 inhibitors to combat obesity. His stance has sparked debates, such ...